---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-309122"
form_type: "8-K"
ticker: "CLYM"
cik: "0001768446"
company_name: "Climb Bio, Inc."
filed_at: "2022-12-20T23:59:59+00:00"
generated_at: "2026-06-21T01:50:51.994963+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Eliem Therapeutics sets 2023 base salaries and bonuses for named executives

## Summary
- CEO Azelby: $438,750 2022 bonus; 2023 base $702,000, 65% target bonus (company goals only).
- COO/CFO Lavelle: $209,588 2022 bonus; 2023 base $484,380, 45% target bonus.
- CSO Morisset: £145,467 2022 bonus; 2023 base £336,190, 45% target bonus.
- 2023 company performance goals to be set later by Board; individual goals subjective.

## SEC filing metadata
- accession: 0001193125-22-309122
- form_type: 8-K
- ticker: CLYM
- cik: 0001768446
- company_name: Climb Bio, Inc.
- filed_at: 2022-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768446/000119312522309122/0001193125-22-309122-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768446/000119312522309122/d399841d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-309122
- JSON: https://secwatch.observer/filing/0001193125-22-309122.json
- Plain text: https://secwatch.observer/filing/0001193125-22-309122.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.